You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Antimicrobial Treatment in Burn Graft Biomaterials

    SBC: ACRYMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Burn injuries represent the most terrifying and horrific trauma imaginable. This image is conditioned, in part, from the appearance of surviving bum victims that have been horribly scarred and disfigured follow

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Incorporating Bone Minerals into Orthopaedic Surfaces

    SBC: ADVANCED SURFACES AND PROCESSES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Submerged Electro-Spark Deposition (SESD, US patent pending), developed at Advanced Surfaces And Processes, Inc., is a surface modification technique. Any conductive surface can be modified with regards to surface texture and chemical composition. The objective of the present proposal is to use SESD to incorporate appreciable amounts of bone mineral elements, i ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Morpholino Antisense Drugs for Hepatitis C Virus

    SBC: Avi Biopharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) causes a persistent infection in most humans exposed to the virus. HCV infection in time can lead to cirrhosis and hepatocellular carcinoma. Although the annual number of newly infected patients has dropped significantly over the past decade, about 4 million people are currently persistently infected in the USA. There is presently no un ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. EFFECTS OF TF/FVIIa INHIBITION IN CRP TRANSGENIC MICE

    SBC: BIOCRYST PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This program is focused on the development of a small-molecule tissue factor/factor Vlla (TF/FVIla) inhibitor with unique anti-inflammatory properties as a novel therapeutic agent for the treatment of unstable angina.

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Multiscale Tumor Model for Cancer Treatment Prototyping

    SBC: CFD RESEARCH CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Cancer is the second leading cause of death in the U.S. Despite very active research in the area, the number of deaths related to cancer has not fallen significantly in the past decade. A major problem associated wi

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Microfluidic Chip and Software for Microvascular Studies

    SBC: CFD RESEARCH CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Particle adhesion to tissue (vascular endothelium) depends critically upon particle/cell property (size, receptors), scale/geometric features of vasculature (diameter, bifurcation etc.) and local hemodynamic factors

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Novel Thrombectomy Catheter for Ischemic Stroke

    SBC: CFD RESEARCH CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of the proposed study is to design, fabricate and test an optimal thrombectomy catheter for treatment of ischemic stroke. The size/extent of ischemic damage following a stroke may be dramatically reduced (and

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel, Low Power, High Throughput, High Efficiency, Scalable Electrostatic Bioaerosol Sampler

    SBC: CFD RESEARCH CORPORATION            Topic: HSB041003

    Current bioaerosol monitoring strategies rely on inertia-based sampling and suffer from high power consumption and low efficiency limitations. In contrast, our overall objective is to design and demonstrate a novel electrostatic sampler that provides dramatic improvements including low power requirement (90% for 1-10mm), high viability (>80%), scalability for varying threat scenarios, low noise, a ...

    SBIR Phase I 2004 Department of Homeland Security
  9. Home Sensor Data Fusion to Support Aging in Place

    SBC: CLEVERSET, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The research objective of the proposed work is to fuse sensor data to infer behavior of occupants in a home setting. The sensor data have been collected by CareWheels Corporation, a Section 501 (c)(3) non-profit pu

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Enhanced Long-Term Care of Severe Respiratory Failure

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Current management of acute respiratory distress syndrome (ARDS) is suboptimal. Arteriovenous carbon dioxide removal (AVCO2R) combined with mild oxygen ventilation has shown promise. AVCO2R is mild pumpless technique u

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government